Abstract

Amyloid-like aggregates of the microtubule-associated protein Tau are associated with several neurodegenerative disorders including Alzheimer’s disease. The existence of cellular machinery for the removal of such aggregates has remained unclear, as specialized disaggregase chaperones are thought to be absent in mammalian cells. Here we show in cell culture and in neurons that the hexameric ATPase valosin-containing protein (VCP) is recruited to ubiquitylated Tau fibrils, resulting in their efficient disaggregation. Aggregate clearance depends on the functional cooperation of VCP with heat shock 70 kDa protein (Hsp70) and the ubiquitin-proteasome machinery. While inhibition of VCP activity stabilizes large Tau aggregates, disaggregation by VCP generates seeding-active Tau species as byproduct. These findings identify VCP as a core component of the machinery for the removal of neurodegenerative disease aggregates and suggest that its activity can be associated with enhanced aggregate spreading in tauopathies.

Tau aggregates are associated with several neurodegenerative disorders. In this work, I. Saha and colleagues show that valosin-containing protein (VCP) recruited to Tau fibrils disaggregates them. However, this process comes at a cost: it generates seeding-active Tau species as byproduct.

Details

Title
The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
Author
Saha, Itika 1 ; Yuste-Checa, Patricia 1   VIAFID ORCID Logo  ; Da Silva Padilha, Miguel 2 ; Guo, Qiang 3   VIAFID ORCID Logo  ; Körner, Roman 4 ; Holthusen, Hauke 4   VIAFID ORCID Logo  ; Trinkaus, Victoria A. 5 ; Dudanova, Irina 2   VIAFID ORCID Logo  ; Fernández-Busnadiego, Rubén 6   VIAFID ORCID Logo  ; Baumeister, Wolfgang 7   VIAFID ORCID Logo  ; Sanders, David W. 8 ; Gautam, Saurabh 9   VIAFID ORCID Logo  ; Diamond, Marc I. 10   VIAFID ORCID Logo  ; Hartl, F. Ulrich 11   VIAFID ORCID Logo  ; Hipp, Mark S. 12   VIAFID ORCID Logo 

 Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA (GRID:grid.513948.2) (ISNI:0000 0005 0380 6410) 
 Max Planck Institute for Biological Intelligence, Molecular Neurodegeneration Group, Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091); Max Planck Institute for Biological Intelligence, Department of Molecules – Signaling – Development, Martinsried, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091); University of Cologne, Center for Anatomy, Faculty of Medicine and University Hospital Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777) 
 Max Planck Institute of Biochemistry, Department of Structural Molecular Biology, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Peking University, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences and Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319) 
 Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X) 
 Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Max Planck Institute of Biochemistry, Department of Structural Molecular Biology, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3) 
 Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA (GRID:grid.513948.2) (ISNI:0000 0005 0380 6410); Max Planck Institute of Biochemistry, Department of Structural Molecular Biology, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); University Medical Center Göttingen, Institute of Neuropathology, Göttingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331); University of Göttingen, Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), Göttingen, Germany (GRID:grid.7450.6) (ISNI:0000 0001 2364 4210) 
 Max Planck Institute of Biochemistry, Department of Structural Molecular Biology, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X) 
 University of Texas Southwestern Medical Center, Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); Princeton University, Department of Chemical and Biological Engineering, Princeton, USA (GRID:grid.16750.35) (ISNI:0000 0001 2097 5006) 
 Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Boehringer Ingelheim International GmbH, Ingelheim, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500); ViraTherapeutics GmbH, Rum, Austria (GRID:grid.420061.1) 
10  University of Texas Southwestern Medical Center, Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
11  Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA (GRID:grid.513948.2) (ISNI:0000 0005 0380 6410); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3) 
12  Max Planck Institute of Biochemistry, Department of Cellular Biochemistry, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3); Carl von Ossietzky University Oldenburg, School of Medicine and Health Sciences, Oldenburg, Germany (GRID:grid.5560.6) (ISNI:0000 0001 1009 3608); University Medical Center Groningen, University of Groningen, Department of Biomedical Sciences of Cells and Systems, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598) 
Pages
560
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2771822608
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.